BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
CVE-2017-17678 is listed in the HOL Guard supply-chain feed, but affected software is not mapped to a package. Review the upstream advisory for the affected product and vendor guidance. BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
CVE-2017-17678 is listed in the HOL Guard supply-chain feed, but affected software is not mapped to a package. Review the upstream advisory for the affected product and vendor guidance. BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
Reported by NVD (nvd).
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL GuardReported by NVD (nvd).
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL Guard